Neurostimulant use is associated with improved survival in comatose patients after cardiac arrest regardless of electroencephalographic substrate.

Alexis Steinberg, Jon C Rittenberger, Maria Baldwin, John Faro, Alexandra Urban, Naoir Zaher, Clifton W Callaway, Jonathan Elmer, Pittsburgh Post-Cardiac Arrest Service
Author Information
  1. Alexis Steinberg: Department of Neurology, University of Pittsburgh, Pittsburgh, PA, United States.
  2. Jon C Rittenberger: Department of Emergency Medicine, University of Pittsburgh, Pittsburgh, PA, United States. Electronic address: rittjc@upmc.edu.
  3. Maria Baldwin: Department of Neurology, University of Pittsburgh, Pittsburgh, PA, United States; Department of Neurology, Pittsburgh VA Medical Center, Pittsburgh PA, United States.
  4. John Faro: Department of Emergency Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
  5. Alexandra Urban: Department of Neurology, University of Pittsburgh, Pittsburgh, PA, United States.
  6. Naoir Zaher: Department of Neurology, University of Pittsburgh, Pittsburgh, PA, United States.
  7. Clifton W Callaway: Department of Emergency Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
  8. Jonathan Elmer: Department of Emergency Medicine, University of Pittsburgh, Pittsburgh, PA, United States; Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, United States.

Abstract

AIM: Identify EEG patterns that predict or preclude favorable response in comatose post-arrest patients receiving neurostimulants.
METHODS: We examined a retrospective cohort of consecutive electroencephalography (EEG)-monitored comatose post-arrest patients. We classified the last day of EEG recording before neurostimulant administration based on continuity (continuous/discontinuous), reactivity (yes/no) and malignant patterns (periodic discharges, suppression burst, myoclonic status epilepticus or seizures; yes/no). In subjects who did not receive neurostimulants, we examined the last 24h of available recording. For our primary analysis, we used logistic regression to identify EEG predictors of favorable response to treatment (awakening).
RESULTS: In 585 subjects, mean (SD) age was 57 (17) years and 227 (39%) were female. Forty-seven patients (8%) received a neurostimulant. Neurostimulant administration independently predicted improved survival to hospital discharge in the overall cohort (adjusted odds ratio (aOR) 4.00, 95% CI 1.68-9.52) although functionally favorable survival did not differ. No EEG characteristic predicted favorable response to neurostimulants. In each subgroup of unfavorable EEG characteristics, neurostimulants were associated with increased survival to hospital discharge (discontinuous background: 44% vs 7%, P=0.004; non-reactive background: 56% vs 6%, P<0.001; malignant patterns: 63% vs 5%, P<0.001).
CONCLUSION: EEG patterns described as ominous after cardiac arrest did not preclude survival or awakening after neurostimulant administration. These data are limited by their observational nature and potential for selection bias, but suggest that EEG patterns alone should not affect consideration of neurostimulant use.

Keywords

References

Eur J Pediatr. 2001 Jun;160(6):401 [PMID: 11421428]
Neuron. 2003 Jun 5;38(5):678-80 [PMID: 12797952]
Clin Neurol Neurosurg. 2006 Sep;108(6):539-42 [PMID: 16226371]
J Child Neurol. 2006 Oct;21(10):879-85 [PMID: 17005105]
Resuscitation. 2008 Nov;79(2):198-204 [PMID: 18951113]
Neurology. 2009 Feb 24;72(8):744-9 [PMID: 19237704]
Restor Neurol Neurosci. 2009;27(4):277-83 [PMID: 19738321]
Resuscitation. 2010 Jul;81(7):893-7 [PMID: 20418008]
Crit Care Med. 2010 Aug;38(8):1709-17 [PMID: 20526197]
Lancet Neurol. 2011 Feb;10(2):123-30 [PMID: 21216670]
Resuscitation. 2011 Aug;82(8):1036-40 [PMID: 21524837]
Resuscitation. 2011 Sep;82(9):1180-5 [PMID: 21592642]
Neurocrit Care. 2012 Feb;16(1):114-22 [PMID: 21638118]
Resuscitation. 2011 Nov;82(11):1399-404 [PMID: 21756969]
N Engl J Med. 2012 Mar 1;366(9):819-26 [PMID: 22375973]
Neurocrit Care. 2012 Aug;17(1):3-23 [PMID: 22528274]
Resuscitation. 2013 Jun;84(6):818-24 [PMID: 23178867]
J Clin Neurophysiol. 2013 Feb;30(1):1-27 [PMID: 23377439]
Am J Med Sci. 2014 Mar;347(3):178-82 [PMID: 23462249]
Funct Neurol. 2013 Oct-Dec;28(4):259-64 [PMID: 24598393]
Resuscitation. 2014 Aug;85(8):1025-9 [PMID: 24795283]
Resuscitation. 2015 Apr;89:86-92 [PMID: 25636896]
Clin Toxicol (Phila). 2015 Mar;53(3):168-77 [PMID: 25650984]
Resuscitation. 2015 May;90:67-72 [PMID: 25737082]
Resuscitation. 2015 May;90:127-32 [PMID: 25779006]
PLoS One. 2015 May 04;10(5):e0124986 [PMID: 25938462]
Resuscitation. 2015 Sep;94:98-105 [PMID: 26025569]
Resuscitation. 2015 Sep;94:73-9 [PMID: 26164682]
Biomed Res Int. 2015;2015:283608 [PMID: 26421282]
Resuscitation. 2016 Jan;98:9-14 [PMID: 26476197]
JAMA. 2015 Oct 20;314(15):1637-8 [PMID: 26501539]
Resuscitation. 2016 May;102:127-35 [PMID: 26836944]
Neurocrit Care. 2016 Dec;25(3):415-423 [PMID: 27033709]
Ann Neurol. 2016 Aug;80(2):175-84 [PMID: 27351833]
Resuscitation. 2016 Nov;108:48-53 [PMID: 27650862]
Curr Opin Neurol. 2016 Dec;29(6):700-705 [PMID: 27748687]
Circulation. 2017 Mar 7;135(10):e146-e603 [PMID: 28122885]

Grants

  1. K12 HL109068/NHLBI NIH HHS
  2. K23 NS097629/NINDS NIH HHS
  3. L30 NS089025/NINDS NIH HHS

MeSH Term

Adult
Aged
Case-Control Studies
Central Nervous System Stimulants
Coma
Electroencephalography
Female
Heart Arrest
Humans
Male
Middle Aged
Outcome Assessment, Health Care
Retrospective Studies

Chemicals

Central Nervous System Stimulants